News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Androgen Receptor Inhibition Increases MHC Class I Expression in Prostate Cancer
Dec 11, 2024, 05:14

Androgen Receptor Inhibition Increases MHC Class I Expression in Prostate Cancer

Elizabeth McKenna, Executive Director of Cancer Discovery at the American Association for Cancer Research, shared a post on X:

“Now online in Cancer Discovery Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer -by Lisa Chesner, Felix Feng, Amy Moran, and colleagues.”

Elizabeth McKenna

Androgen receptor inhibition increases MHC Class I expression and improves immune response in prostate cancer.

Authors: Lisa N. Chesner, Fanny Polesso, Julie N. Graff, Jessica E. Hawley, Alexis K. Smith, Arian Lundberg, Rajdeep Das, Tanushree Shenoy, Martin Sjöström, Faming Zhao, Ya-Mei Hu, Simon Linder, William S. Chen, Reed M. Hawkins, Raunak Shrestha, Xiaolin Zhu, Adam Foye, Haolong Li, Lisa M. Kim, Megha Bhalla, Thomas O’loughlin, Duygu Kuzuoglu-Ozturk, Junjie T. Hua, Michelle L. Badura, Scott Wilkinson, Shana Y. Trostel, Andries M. Bergman, Davide Ruggero, Charles G. Drake, Adam G. Sowalsky, Lawrence Fong, Matthew R. Cooperberg, Wilbert Zwart, Xiangnan Guan, Alan Ashworth, Zheng Xia, David A. Quigley, Luke A. Gilbert, Felix Y. Feng, Amy E. Moran.

MHC

Adam Foye Adam G. Sowalsky Alan Ashworth Alexis K. Smith Amy E. Moran Amy Moran Andries M. Bergman Androgen Receptor Arian Lundberg cancer Cancer Discovery Charles G. Drake David A. Quigley Davide Ruggero Duygu Kuzuoglu-Ozturk Elizabeth McKenna Faming Zhao Fanny Polesso Felix Feng Felix Y. Feng Haolong Li Jessica E. Hawley Julie N. Graff Junjie T. Hua Lawrence Fong Lisa Chesner Lisa M. Kim Lisa N. Chesner Luke A. Gilbert Martin Sjöström Matthew R. Cooperberg Megha Bhalla Michelle L. Badura OncoDaily Oncology prostate cancer Rajdeep Das Raunak Shrestha Reed M. Hawkins Scott Wilkinson Shana Y. Trostel Simon Linder Tanushree Shenoy Thomas O'loughlin Wilbert Zwart William S. Chen Xiangnan Guan Xiaolin Zhu Ya-Mei Hu Zheng Xia
Special Coverage
Science
Apr 15, 2025, 13:59
Bishoy M. Faltas: ctDNA is a key piece of the puzzle in building an integrated precision oncology
Blog
Apr 15, 2025, 13:41
Register for the 3rd OECI Academy Webinar
Science
Apr 15, 2025, 13:29
TALAPRO-2: Miloš Grujić highlights improved quality of life with Talazoparib + Enzalutamide in mCRPC
Blog
Apr 15, 2025, 13:28
Joshua Brody: Combining lymphoma immunotherapy with standard of care
Blog
Apr 15, 2025, 13:18
Hidehito Horinouchi: Afatinib in patients with solid tumors with neuregulin1 (NRG1) fusions
Blog
Apr 15, 2025, 13:09
Fumiko Ladd Chino: Our ongoing work to share freely accessible, cutting-edge, clinically relevant science with the world
Blog
Apr 15, 2025, 13:06
Petros Grivas: Great to spend time at 40 years of Hellenic Society of Medical Oncology
Blog
Apr 15, 2025, 13:00
Join the upcoming bi-weekly Cancer and Aging Research Group (CARG) meeting
Insight
Apr 15, 2025, 12:48
Yvonne Bombard presented on Mitigating Disparities in Hereditary Cancer Genetics at 2025 OMPRN Webinar
Blog
Apr 15, 2025, 12:44
CancerWorld Cover Conversations - A chance to connect with the giants in the field of oncology
Blog
Apr 15, 2025, 12:42
Fumiko Ladd Chino: Projected Lifetime Cancer Risks From Current Computed Tomography Imaging
Blog
Apr 15, 2025, 12:34
Chandler Park: Great privilege to advocate for cancer patients at the 2025 ASCO Advocacy Summit